171 related articles for article (PubMed ID: 28396397)
1. Dimerization of Tie2 mediated by its membrane-proximal FNIII domains.
Moore JO; Lemmon MA; Ferguson KM
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4382-4387. PubMed ID: 28396397
[TBL] [Abstract][Full Text] [Related]
2. Ligand-independent Tie2 dimers mediate kinase activity stimulated by high dose angiopoietin-1.
Yamakawa D; Kidoya H; Sakimoto S; Jia W; Naito H; Takakura N
J Biol Chem; 2013 May; 288(18):12469-77. PubMed ID: 23504320
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of Tie2 activation and Tie2/Tie1 heterodimerization.
Leppänen VM; Saharinen P; Alitalo K
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4376-4381. PubMed ID: 28396439
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex.
Barton WA; Tzvetkova-Robev D; Miranda EP; Kolev MV; Rajashankar KR; Himanen JP; Nikolov DB
Nat Struct Mol Biol; 2006 Jun; 13(6):524-32. PubMed ID: 16732286
[TBL] [Abstract][Full Text] [Related]
5. Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands.
Seegar TC; Eller B; Tzvetkova-Robev D; Kolev MV; Henderson SC; Nikolov DB; Barton WA
Mol Cell; 2010 Mar; 37(5):643-55. PubMed ID: 20227369
[TBL] [Abstract][Full Text] [Related]
6. Roles of the receptor tyrosine kinases Tie1 and Tie2 in mediating the effects of angiopoietin-1 on endothelial permeability and apoptosis.
Milner CS; Hansen TM; Singh H; Brindle NP
Microvasc Res; 2009 Mar; 77(2):187-91. PubMed ID: 18848573
[TBL] [Abstract][Full Text] [Related]
7. The molecular balance between receptor tyrosine kinases Tie1 and Tie2 is dynamically controlled by VEGF and TNFα and regulates angiopoietin signalling.
Singh H; Hansen TM; Patel N; Brindle NP
PLoS One; 2012; 7(1):e29319. PubMed ID: 22235284
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for angiopoietin-1-mediated signaling initiation.
Yu X; Seegar TC; Dalton AC; Tzvetkova-Robev D; Goldgur Y; Rajashankar KR; Nikolov DB; Barton WA
Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7205-10. PubMed ID: 23592718
[TBL] [Abstract][Full Text] [Related]
9. Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival.
Yuan HT; Venkatesha S; Chan B; Deutsch U; Mammoto T; Sukhatme VP; Woolf AS; Karumanchi SA
FASEB J; 2007 Oct; 21(12):3171-83. PubMed ID: 17504972
[TBL] [Abstract][Full Text] [Related]
10. Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2.
Kim KT; Choi HH; Steinmetz MO; Maco B; Kammerer RA; Ahn SY; Kim HZ; Lee GM; Koh GY
J Biol Chem; 2005 May; 280(20):20126-31. PubMed ID: 15769741
[TBL] [Abstract][Full Text] [Related]
11. Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapy.
Shlamkovich T; Aharon L; Barton WA; Papo N
Oncotarget; 2017 May; 8(20):33571-33585. PubMed ID: 28422724
[TBL] [Abstract][Full Text] [Related]
12. Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2.
Saharinen P; Kerkelä K; Ekman N; Marron M; Brindle N; Lee GM; Augustin H; Koh GY; Alitalo K
J Cell Biol; 2005 Apr; 169(2):239-43. PubMed ID: 15851516
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases.
Singh H; Milner CS; Aguilar Hernandez MM; Patel N; Brindle NP
Cell Signal; 2009 Aug; 21(8):1346-50. PubMed ID: 19376222
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of angiogenesis and survival of endothelial cells by human monoclonal Tie2 receptor antibody.
Hwang B; Lee SH; Kim JS; Moon JH; Jeung IC; Lee NG; Park J; Hong HJ; Cho YL; Jung H; Park YJ; Lee SJ; Lee HG; Kim WK; Han BS; Bae KH; Chung SJ; Kwon YG; Lee SC; Kim SJ; Min JK
Biomaterials; 2015 May; 51():119-128. PubMed ID: 25771003
[TBL] [Abstract][Full Text] [Related]
15. In vitro inhibition of cancer angiogenesis and migration by a nanobody that targets the orphan receptor Tie1.
Meltzer M; Eliash N; Azoulay Z; Hadad U; Papo N
Cell Mol Life Sci; 2022 May; 79(6):312. PubMed ID: 35604495
[TBL] [Abstract][Full Text] [Related]
16. Structure of the extracellular domain of Tie receptor tyrosine kinases and localization of the angiopoietin-binding epitope.
Macdonald PR; Progias P; Ciani B; Patel S; Mayer U; Steinmetz MO; Kammerer RA
J Biol Chem; 2006 Sep; 281(38):28408-14. PubMed ID: 16849318
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis.
Fukuhara S; Sako K; Noda K; Zhang J; Minami M; Mochizuki N
Histol Histopathol; 2010 Mar; 25(3):387-96. PubMed ID: 20054809
[TBL] [Abstract][Full Text] [Related]
18. Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2.
Marron MB; Singh H; Tahir TA; Kavumkal J; Kim HZ; Koh GY; Brindle NP
J Biol Chem; 2007 Oct; 282(42):30509-17. PubMed ID: 17728252
[TBL] [Abstract][Full Text] [Related]
19. Structure of the Tie2 RTK domain: self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail.
Shewchuk LM; Hassell AM; Ellis B; Holmes WD; Davis R; Horne EL; Kadwell SH; McKee DD; Moore JT
Structure; 2000 Nov; 8(11):1105-13. PubMed ID: 11080633
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into the clustering and activation of Tie2 receptor mediated by Tie2 agonistic antibody.
Jo G; Bae J; Hong HJ; Han AR; Kim DK; Hong SP; Kim JA; Lee S; Koh GY; Kim HM
Nat Commun; 2021 Nov; 12(1):6287. PubMed ID: 34725372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
